SPARC Intraday Analysis...

SPARC Share Price

Open 338.40 Change Price %
High 368.60 1 Day 13.15 3.90
Low 335.00 1 Week 21.50 6.53
Close 350.60 1 Month 21.00 6.37
Volume 1887477 1 Year -41.15 -10.50
52 Week High 414.90
52 Week Low 245.20
SPARC Important Levels
Resistance 2 381.75
Resistance 1 368.91
Pivot 351.40
Support 1 332.29
Support 2 319.45
NSE INDIA Most Active Stocks
GMRINFRA 13.70 0.74%
NOIDATOLL 14.75 -16.90%
ASHOKLEY 90.25 6.30%
SUZLON 15.15 3.77%
IDFC 69.90 2.49%
RCOM 46.80 1.85%
ADANIPOWER 27.35 2.05%
ICICIBANK 276.85 -2.62%
HDIL 83.25 4.00%
JPASSOCIAT 11.15 1.83%
NSE INDIA Top Gainers Stocks
CINELINE 87.00 20.00%
ORISSAMINE 2448.65 20.00%
TIRUMALCHM 871.00 20.00%
ASTEC 542.20 20.00%
HANUNG 6.60 20.00%
GREENFIRE 2.40 20.00%
SPYL 1.80 20.00%
GOLDENTOBC 64.65 19.94%
WELINV 86.65 15.53%
VISHNU 336.95 15.41%
NSE INDIA Top Losers Stocks
BIRLACOT 0.05 -50.00%
RASOYPR 0.15 -25.00%
KSERASERA 0.15 -25.00%
EVERONN 11.70 -19.86%
GOKEX 68.50 -19.36%
NOIDATOLL 14.75 -16.90%
SRGINFOTEC 0.25 -16.67%
DENORA 282.75 -14.60%
RAJRAYON 0.30 -14.29%
ATNINTER 0.40 -11.11%

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 3
As on 28th Oct 2016 SPARC Share Price closed @ 350.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 318.69 & Buy for SHORT-TERM with Stoploss of 348.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for October
1st Target up-side 360.85
2nd Target up-side 392.71
3rd Target up-side 424.57
1st Target down-side 269.95
2nd Target down-side 238.09
3rd Target down-side 206.23
SPARC Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 61.46 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -30.61 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 314.97
10 Day Avg Volume Traded 376.25 % More then 10 Day Average Volume
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website
SPARC Address
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.